Profile data is unavailable for this security.
About the company
Next Science Limited is an Australia-based medical technology company. The Company’s primary focus is on the development and commercialization of its proprietary XBIO technology to reduce the impact of biofilm-based infections on human health. XBIO is a non-toxic technology with an efficacy in eradicating both biofilm-based and free-floating bacteria. The Company’s products include XPERIENCE, Blast X, SurgX and Bactisure. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SurgX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel with sustained effectiveness for up to five days. BLASTX Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing.
- Revenue in AUD (TTM)34.90m
- Net income in AUD-20.22m
- Incorporated2017
- Employees--
- LocationNext Science LtdTower BThe Zenith L 19, 821 Pacific HighwayChatswood 2000AustraliaAUS
- Phone+61 28607-5124
- Websitehttps://www.nextscience.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nyrada Inc | 3.40m | -1.39m | 23.06m | -- | -- | 3.97 | -- | 6.78 | -0.0081 | -0.0081 | 0.0209 | 0.0277 | 0.6147 | -- | -- | -- | -25.13 | -53.28 | -29.75 | -62.52 | -- | -- | -40.89 | -236.15 | -- | -- | 0.00 | -- | 115.55 | 46.42 | 82.12 | -- | -- | -- |
| Oncosil Medical Ltd | 583.20k | -11.91m | 31.32m | 2.00 | -- | 4.92 | -- | 53.70 | -0.0054 | -0.0054 | 0.0003 | 0.0014 | 0.0641 | -- | 3.12 | -- | -130.97 | -67.66 | -162.31 | -77.45 | -158.87 | -- | -2,042.81 | -768.23 | -- | -- | 0.0147 | -- | 35.54 | -31.37 | -5.03 | -- | 67.76 | -- |
| Little Green Pharma Ltd | 25.63m | -8.15m | 34.83m | -- | -- | 0.4467 | -- | 1.36 | -0.0272 | -0.0272 | 0.0856 | 0.2574 | 0.2772 | 1.05 | 12.29 | -- | -8.82 | -- | -9.74 | -- | 53.18 | -- | -31.81 | -- | 1.39 | -18.90 | 0.0624 | -- | 29.07 | -- | 4.72 | -- | -- | -- |
| Starpharma Holdings Ltd | 9.76m | -8.17m | 41.39m | 50.00 | -- | 1.45 | -- | 4.24 | -0.0198 | -0.0198 | 0.0237 | 0.0682 | 0.2195 | 0.244 | 1.20 | -- | -18.37 | -27.20 | -24.10 | -33.05 | 93.52 | 77.48 | -83.69 | -269.74 | 4.58 | -- | 0.1115 | -- | 131.84 | 29.10 | 47.79 | -- | -22.29 | -- |
| Next Science Ltd | 34.90m | -20.22m | 45.28m | -- | -- | 4.27 | -- | 1.30 | -0.0753 | -0.0753 | 0.128 | 0.0363 | 1.97 | 5.34 | 8.04 | -- | -113.88 | -74.40 | -168.92 | -90.31 | 78.83 | 76.98 | -57.93 | -128.26 | 1.96 | -- | 0.1045 | -- | 89.36 | 50.80 | -28.29 | -- | -2.28 | -- |
| Inoviq Ltd | 791.70k | -6.55m | 50.19m | 85.00 | -- | 2.38 | -- | 63.39 | -0.0709 | -0.0709 | 0.0086 | 0.1894 | 0.0366 | 4.54 | 0.6418 | -- | -30.33 | -44.62 | -32.64 | -47.55 | 89.77 | -- | -827.88 | -1,928.52 | 7.06 | -- | 0.0198 | -- | 5.29 | 146.33 | 26.92 | -- | -- | -- |
| Medical Developments International Ltd | 33.15m | -40.99m | 51.26m | 68.00 | -- | 0.8815 | -- | 1.55 | -0.4627 | -0.4627 | 0.3741 | 0.5162 | 0.4131 | 1.02 | 4.14 | -- | -51.09 | -15.81 | -60.56 | -17.79 | 73.50 | 70.98 | -123.66 | -52.49 | 1.82 | -- | 0.0476 | -- | 2.51 | 9.22 | -630.83 | -- | -20.32 | -- |
| Radiopharm Theranostics Ltd | 299.23k | -47.95m | 52.15m | -- | -- | 0.3929 | -- | 174.28 | -0.1261 | -0.1261 | 0.0008 | 0.0611 | 0.0041 | -- | 0.1097 | -- | -65.24 | -- | -82.85 | -- | -- | -- | -16,024.17 | -- | -- | -3.91 | 0.00 | -- | 2.35 | -- | -38.54 | -- | -- | -- |
| Vitura Health Ltd | 123.87m | 3.51m | 55.28m | 119.00 | 15.56 | 1.43 | 11.31 | 0.4463 | 0.0062 | 0.0062 | 0.2165 | 0.0674 | 2.10 | 15.04 | 10.74 | 1,040,932.00 | 5.50 | 13.50 | 7.70 | 18.51 | 27.63 | 32.41 | 2.62 | 6.19 | 1.11 | 30.48 | 0.2228 | -- | 5.56 | -- | -74.57 | -- | 155.80 | -- |
| Syntara Ltd | 5.43m | -13.67m | 56.30m | 107.00 | -- | 10.46 | -- | 10.37 | -0.0157 | -0.016 | 0.0057 | 0.0039 | 0.3155 | -- | 0.7918 | -- | -79.44 | -30.68 | -130.63 | -40.26 | -- | -- | -251.77 | -74.66 | -- | -484.90 | 0.0474 | -- | -7.92 | -15.43 | -1.77 | -- | -62.79 | -- |
